Cancer

Novel findings support original categorization of HER2

(HealthDay)—The original classifications of human epidermal growth factor receptor 2 (HER2) categorization by fluorescent in situ hybridization (FISH) have been supported by recent data, according to a report published ...

Sep 01, 2016
popularity0 comments 0

CRISPR/Cas9 technology to inactivate cancer mutations

As for many other biomedical and biotechnology disciplines, the genome scissor "CRISPR/Cas9" also opens up completely new possibilities for cancer research. Scientists of the National Center for Tumor Disease (NCT), the German ...

Aug 31, 2016
popularity0 comments 0